Compare NVMI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVMI | PEN |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 12.6B |
| IPO Year | 2001 | 2015 |
| Metric | NVMI | PEN |
|---|---|---|
| Price | $381.32 | $318.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 16 |
| Target Price | ★ $431.88 | $360.14 |
| AVG Volume (30 Days) | ★ 420.9K | 287.2K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 1.70 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $20.94 | $14.34 |
| Revenue Next Year | $19.53 | $13.71 |
| P/E Ratio | ★ $56.79 | $187.29 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $266.43 | $221.26 |
| 52 Week High | $615.99 | $362.41 |
| Indicator | NVMI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 54.37 | 41.79 |
| Support Level | $356.50 | $315.60 |
| Resistance Level | $387.71 | $320.45 |
| Average True Range (ATR) | 10.88 | 1.54 |
| MACD | 4.78 | 0.06 |
| Stochastic Oscillator | 89.15 | 45.56 |
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.